Using national health policies to improve access to palliative care medications in the community

Journal of Pain and Symptom Management
Debra RowettDavid C Currow

Abstract

Access to affordable priority palliative care medicines needs to be informed by good clinical data from well-conducted clinical trials designed to address efficacy, cost-effectiveness, and safety. Availability of priority palliative care symptom control medicines improves the provision of palliation in the place of patient's choice including the community. Within Australia, a National Medicines Policy and a Palliative Care Strategy endorsed by Federal and State and Territory health ministers have facilitated a process to improve the evidence for palliative clinical practice and, through this, improve community availability of key medications for people at the end of life. The initiative, coordinated by a working party under government auspices, has brought together medicine regulators, the pharmaceutical industry, government, policy makers, and clinicians. The brief was to improve availability of key palliative care medications within the current national drug regulatory and funding frameworks. The results to date include: a palliative care section within the Pharmaceutical Benefits Scheme generating the first ever patient-defined section; medicines not previously listed now available; commitment of AU$9.46 M for a national mul...Continue Reading

References

Nov 4, 1992·JAMA : the Journal of the American Medical Association·UNKNOWN Evidence-Based Medicine Working Group
Jan 13, 1996·BMJ : British Medical Journal·D L SackettW S Richardson
Aug 1, 2002·International Journal of Palliative Nursing·L LuddingtonB Livesley
Aug 24, 2004·BMJ : British Medical Journal·Christine Y LuJames Bertouch
Apr 3, 2007·Journal of the American Geriatrics Society·David C CurrowTania M Shelby-James
Apr 25, 2007·Archives of Internal Medicine·Sarah N HilmerDarrell R Abernethy
May 8, 2007·Journal of Pain and Symptom Management·Jan StjernswärdFrank D Ferris

❮ Previous
Next ❯

Citations

Jan 22, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·David Christopher CurrowJanet Hardy
May 18, 2013·Journal of Palliative Medicine·Paul A Tait, Timothy H M To
Jun 22, 2015·Australian Health Review : a Publication of the Australian Hospital Association·Nikki McCaffreyDavid Currow
Jan 7, 2016·Journal of Pain and Symptom Management·Nikki McCaffreyDavid C Currow
Jul 14, 2010·Journal of Pain and Symptom Management·Janet R HardyCarol Douglas
Jul 21, 2009·Journal of Pain and Symptom Management·Robert GordonJanette Green
Sep 24, 2008·Journal of Pain and Symptom Management·David C CurrowAmy P Abernethy
Jun 22, 2010·Internal Medicine Journal·J HardyD C Currow
Jun 21, 2014·BMJ Supportive & Palliative Care·Paul Anthony TaitDebra S Rowett
Mar 29, 2014·Australian Health Review : a Publication of the Australian Hospital Association·Kate SwetenhamDavid Stephenson
Jun 3, 2014·The Medical Journal of Australia·David C Currow, Lloyd N Sansom
Mar 6, 2010·The Medical Journal of Australia·Tania Shelby-JamesDavid C Currow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.